Abstract:2423 Cyclopentenone prostaglandins (cyPGs) exert diverse cellular functions, such as anti-inflammatory and cytoprotective effects, via multiple mechanisms. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), a representative cyPG of the J series, has been reported to directly inhibit the activity of the transcription factors, such as AP-1 and NF-κB. In the present study, we found that human breast cancer (MCF-7) cells treated with 15d-PGJ2 rapidly accumulated the tumor suppressor gene p53 protein in both cytosolic and nuclear fractions. Under the same experimental conditions, however, the mRNA level of p53 remained unchanged. In addition, 15d-PGJ2 significantly decreased p53 DNA binding as well as activity of p21WAF1 promoter containing a p53-binding site in MCF-7 cells. We observed that the majority of accumulated p53 in 15d-PGJ2-treated MCF-7 cells represents the changed mutant form of p53 and ubiquitinated p53 as assessed by immunoprecipitation and immunofluorscence assays. Murine double-minute 2 (MDM2), a zinc finger protein, is known to negatively regulate p53. 15d-PGJ2 treatment caused failure of proper p53-MDM2 interaction in MCF-7 cells which could stabilize the abnormal p53 protein by blocking MDM2-mediated degradation. We hypothesized that 15d-PGJ2 could covalently modify p53, which may hamper DNA binding of this redox-sensitive transcription factor. In support of this assumption, 15d-PGJ2 treated to both recombinant p53 and MCF-7 nuclear extracts diminished the DNA binding ability of p53 in a concentration-dependent manner. In addition, covalent binding of 15d-PGJ2 to p53 occurred upon incubation of recombinant p53 with biotinylated 15d-PGJ2. The incorporation of biotinylated 15d-PGJ2 into p53 was abolished by excess 15d-PGJ2 and restored in the presence of dithiothreitol. By using 35S-labeled translated p53, we could identify to cysteine 277 as a putative site of modification of p53 by 15d-PGJ2. The DNA binding ability of a mutant p53 in which Cys-277 was substituted by Ala was virtually unaffected by 15d-PGJ2. It is anticipated that the electrophilic carbon center located in the α,β-unsaturated carbonyl moiety of the cyclopentenone ring might be critical for the 15d-PGJ2-induced covalent modification of p53 at Cys-277 which hampered its degradation as well as DNA binding. MCF-7 cells treated with 9,10-dihydro-15-deoxy-Δ12,14-prostaglandin J2 that lacks the electrophilic α,β-unsaturated functionality failed to inhibit p53 DNA binding activity, lending further support to the above assumption. In conclusion, 15d-PGJ2, by covalently modifying cysteine 277 of p53, abrogates p53 DNA binding, leading to functional inactivation of this tumor suppressor.

Modulation of (±)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase

Phosphorylation of the α-subunit of the eukaryotic initiation factor-2 (eIF2α) alleviates benzo[a]pyrene-7,8-diol-9,10-epoxide induced cell cycle arrest and apoptosis in human cells.

DNA synthesis inhibition in response to benzo[a]pyrene dihydrodiol epoxide is associated with attenuation of p(34)cdc2: Role of p53

The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice

Cysteine 277 As a Putative Site of P53 for Covalent Modification with 15-Deoxy-δ12,14-prostaglandin J2 : Implications for Functional Inactivation of P53

Benzo[a]pyrene treatment leads to changes in nuclear protein expression and alternative splicing.

P53 and P21(waf1) Are Recruited to Distinct PML-Containing Nuclear Foci in Irradiated and Nutlin-3a-Treated U2OS Cells

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

The Catalytic Subunit of DNA-dependent Protein Kinase Selectively Regulates P53-Dependent Apoptosis but Not Cell-Cycle Arrest.

DNA-dependent Protein Kinase-independent Activation of p53 in Response to DNA Damage

The impact of p53 function on the metabolic activation of the carcinogenic air pollutant 3-nitrobenzanthrone and its metabolites 3-aminobenzanthrone and N-hydroxy-3-aminobenzanthrone in human cells

Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells.

Induction of Cellular P53 Activity by DNA-Damaging Agents and Growth Arrest

Antisense GADD45 Expression Results in Decreased DNA Repair and Sensitizes Cells to U.v.-Irradiation or Cisplatin.

P73 Coordinates with Δ133p53 to Promote DNA Double-Strand Break Repair

An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of P53/p21waf1/cip1 in Response to 5-Aza-2′-deoxycytidine Treatment

Protein adduction causes non-mutational inhibition of p53 tumor suppressor

Poly(ADP-ribose) Glycohydrolase Silencing Down-Regulates TCTP and Cofilin-1 Associated with Metastasis in Benzo(a)pyrene Carcinogenesis.

Inactivation Of P53 Increases The Cytotoxicity Of Camptothecin In Human Colon Hct116 And Breast Mcf-7 Cancer Cells

Homeostatic Regulation of Base Excision Repair by A P53-Induced Phosphatase - Linking Stress Response Pathways with Dna Repair Proteins

Phosphorylation of p53 by Cdk5 contributes to benzo[a]pyrene‐induced neuronal apoptosis